Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
67
Participants
Timeline
Start Date
August 20, 2018
Primary Completion Date
October 24, 2018
Study Completion Date
January 22, 2019
Conditions
Vitamin D InsufficiencySecondary Hyperparathyroidism
Interventions
DRUG
CTAP101 Capsules
Calcifediol Extended-Release Capsules
Trial Locations (1)
90630
WCCT Global, Inc., Cypress
All Listed Sponsors
lead
OPKO Health, Inc.
INDUSTRY
NCT03660800 - Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects | Biotech Hunter | Biotech Hunter